Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rodos BioTarget GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10828
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rodos BioTarget GmbH (RBT) is a biopharmaceutical company that develops drug delivery platforms. The company provides products such as targosphere, targobiotics and targovir. Its targosphere finds application in treating various infectious diseases such as virus caused HCV and hepatitis c and HIV and AIDS; and bacteria caused tuberculosis, legionellosis, methicillin-resistant staphylococcus aureus, and others. RBT’s technology platform targosphere enables the targeted delivery of active agents and vaccines into antigen-presenting cells. The company’s targovir also develops CLR-TS for targeted delivery of antivirals to eradicate intracellular viral reservoirs in the form of infectious virions and proviral DNA integrated into the host cell’s genome. It has partnership with university and institute. RBT is headquartered in Hannover, Germany.

Rodos BioTarget GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Rodos BioTarget Raises US$3.4 Million In Growth Financing 11
Partnerships 12
Rodos Biotarget and Pharis Biotec Enter into Co-Development Agreement 12
Rodos BioTarget Enters into Agreement with Biozeus 13
Rodos BioTarget GmbH – Key Competitors 14
Rodos BioTarget GmbH – Key Employees 15
Rodos BioTarget GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rodos BioTarget Raises US$3.4 Million In Growth Financing 11
Rodos Biotarget and Pharis Biotec Enter into Co-Development Agreement 12
Rodos BioTarget Enters into Agreement with Biozeus 13
Rodos BioTarget GmbH, Key Competitors 14
Rodos BioTarget GmbH, Key Employees 15

List of Figures
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wuhan Iron and Steel (Group) Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Wuhan Iron and Steel (Group) Co …
  • Comp Safe Support SA (CMP):企業概要、財務及び戦略的SWOT分析
    Summary Comp Safe Support SA (Comp SA) is an information technology company. The company offers IT security and network security solutions and services. Its solutions and services include special security, corporate and network security, system solutions, retail technology, IT services and education …
  • Packaging Corporation of America:企業の戦略・SWOT・財務分析
    SummaryPackaging Corporation of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • The Bidvest Group Limited (BVT):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "The Bidvest Group Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • SJ Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SJ Holdings, Inc. Mergers and A …
  • Acorn International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Acorn International, Inc. Merge …
  • Latvijas Juras medicinas centrs AS (LJM1R):企業概要、財務及び戦略的SWOT分析
    Summary Latvijas Juras medicinas centrs AS (LJMC) is a healthcare service provider. The center provides healthcare and diagnostic services. It provides examinations, such as heart and vascular diagnostics, surgical diagnostics, all kind radiologic diagnostics, magnetic resonance, and gastrointestina …
  • Whole Foods Market Inc:企業のM&A・事業提携・投資動向
    Whole Foods Market Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Whole Foods Market Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Trusted Media Brands, Inc.:企業の戦略的SWOT分析
    Trusted Media Brands, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sinotrans Ltd:企業の戦略・SWOT・財務情報
    Sinotrans Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinotrans Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DR. Chip Biotech Inc. (4131):企業概要、財務及び戦略的SWOT分析
    Summary DR. Chip Biotech Inc. (DR. Chip) is a biotechnology company. The company develops and markets biochips, image analysis devices and software, and biological reagents for medical diagnosis and research applications. Its products include laboratory accessories, food diagnostic arrays, agricultu …
  • Alkermes Plc (ALKS):製薬・医療:M&Aディール及び事業提携情報
    Summary Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-release intramuscular injectable suspen …
  • United Technologies Corporation (UTX)(エネルギー分野):企業M&A動向
    Summary United Technologies Corporation (UTC) is a provider of high-technology products and services to the aerospace and building systems industries. The company’s building systems products portfolio include elevators and escalators, moving walkways, heating, ventilating, air conditioning (HVAC) an …
  • Orient International Enterprise Ltd. (600278):企業財務及び戦略的SWOT分析
    Summary Orient International Enterprise Ltd. (OIE) is a business and consumer services company that integrates commodity trade with modern logistics service and consolidates the industrial operation with capital management. The company’s garment and textile products include home textiles, knitted we …
  • Specialised Therapeutics Australia Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes medicines in various therapeutic areas. The company’s products include abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline products comprise anam …
  • Hersha Hospitality Trust:企業のM&A・提携・投資分析
    Hersha Hospitality Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hersha Hospitality Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Panasonic Mobile Communications Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Panasonic Mobile Communications …
  • Lightbridge Corporation (LTBR)-エネルギー分野:企業M&A・提携分析
    Summary Lightbridge Corporation (Lightbridge) is a nuclear fuel technology company, which develops thorium based nuclear fuel technologies for nuclear reactor systems, that increases the power output of commercial reactors; generates nuclear energy and the amount of nuclear waste on a per-megawatt-h …
  • Andrew Yule & Company Ltd. (526173):企業の財務及び戦略的SWOT分析
    Summary Andrew Yule & Company Ltd. (Andrew Yule) is a clean technology company that provides engineering and environment products. The company offers engineering and environment equipments; lubricants, transformers and switch gears; turnkey projects, lamp filaments and telecommunication systems. Its …
  • Bravo Gold Corp. (formerly Bravo Venture Group, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bravo Gold Corp. (formerly Brav …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆